Begin with the Exit in Mind

News


June 30, 2011 article by Paulina Ibarra

Life Sciences company and investment executives debated the current and future viability of the industry model... see article here

"Wait, Our Model Isn't Dead! We Just Need to Evolve." From the session description:

The life science venture capital model is not dead, but indeed it has changed. As this evolution occurs, it's becoming increasingly difficult for capital-intensive life science companies to raise money. To remain alive and thrive, companies need to know how the investors' models have changed. Surviving VC firms have modified their definitions of the perfect portfolio company, as well as what the exit path looks like when the public markets are not an option. New and creative financing models from VC funds are emerging, as well as a new crop of private equity funds. This session will feature prospering investors discussing how their approach to investing has changed and a company CEO who has successfully navigated the new venture landscape.


Epic BioVentures Hunts $125M First Fund With Speedy Exits In Mind

Reprinted with permission from Dow Jones VentureWire, By Brian Gormley    Original link
When pitching Epic BioVentures, entrepreneurs should have an exit in mind when they walk in the door... Read the interview with Dr. Kirby S. Black, Managing Member (PDF)


Biotech VCs No Longer In A "Field of Dreams"

By Brian Gormley - WSJ BLOGS, Venture Capital Dispatch

Biotech venture capitalists could once get away with "Field of Dreams" tactics, but the recent dearth of exits is forcing them to sharpen their strategies.


Venture firms used to assume that if they built a promising biotech company, acquirers and the public markets would come knocking.... More of the interview with Dr. Kirby S. Black, Managing Member





Charles Hewitt, Ph.D. Selected as Panelist at BIO International Conference

Epic BioVentures, LLC, a venture capital firm focused on early stage medical technology investing, is pleased to announce that Dr. Charles W. Hewitt, Managing Member, has been chosen as a panelist at the upcoming BIO International Conference in Washington, DC June 27-30, 2011. The session, entitled "Wait, Our Model Isn't Dead! We Just Need to Evolve.", will feature prospering investors discussing how their approach to investing has changed and a company CEO who has successfully navigated the new venture landscape. Read the Press Release (PDF)


Charles Hewitt, Ph.D. Given Distinguished Alumni Award by Cal Poly Pomona

charles hewitt cal poly pomona 2011 distinguished alumni award winner
  click to enlarge

Epic BioVentures, LLC, a venture capital firm focused on early stage medical technology investing, is pleased to announce that Dr. Charles W. Hewitt, Managing Member, has been recognized by California Polytechnic University, Pomona with its 2011 Distinguished Alumni Award for the College of Science. This award was created to honor alumni who have attained professional success and maintained personal involvement with their community and the university. Read the Press Release (PDF)